You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CPI-613

Showing 1 - 25 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

Recruiting
  • Pancreas Adenocarcinoma
  • CPI-613® (Dose level -1.0 250 mg/m^2)
  • +6 more
  • Detroit, Michigan
  • +1 more
Nov 9, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CPI 613
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
May 10, 2023

C04.588.274.476.411.307 Trial (CPI-613, modified FFX, Bevacizumab)

Not yet recruiting
  • C04.588.274.476.411.307
  • CPI-613
  • +2 more
  • (no location specified)
Nov 10, 2022

Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)

Active, not recruiting
  • Pancreatic Cancer
  • CPI 613
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022

Lymphoma, Leukemia Trial in United States (CPI-613)

Recruiting
  • Lymphoma
  • Leukemia
  • CPI-613
  • Duarte, California
  • +9 more
Nov 28, 2022

Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • +32 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Feb 6, 2023

Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)

Recruiting
  • Sarcoma, Clear Cell
  • CPI-613 + Hydroxychloroquine
  • Duarte, California
  • +7 more
Nov 10, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • 6,8-bis(benzylthio)octanoic acid
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 22, 2021

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Biliary Tract Cancer Trial in United States (CPI 613, Gemcitabine, Cisplatin)

Recruiting
  • Biliary Tract Cancer
  • CPI 613
  • +2 more
  • Tucson, Arizona
  • +9 more
Feb 18, 2022

Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma, Non Hodgkin Lymphoma Trial in Winston-Salem (CPI 613, Bendamustine)

Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Aug 27, 2021

Previously Treated MDS Trial in Winston-Salem (6,8-bis(benzylthio)octanoic acid)

Terminated
  • Previously Treated Myelodysplastic Syndromes
  • 6,8-bis(benzylthio)octanoic acid
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 1, 2021

MDS, Progressive Disease Trial in Buffalo, Winston-Salem (CPI-613, Hydroxychloroquine)

Withdrawn
  • Myelodysplastic Syndromes
  • Progressive Disease
  • Buffalo, New York
  • +1 more
Apr 8, 2021

Relapsed/Refractory Acute Myeloid Leukemia Trial in Worldwide (CPI-613 + High Dose Cytarabine and Mitoxantrone, High Dose

Terminated
  • Relapsed/Refractory Acute Myeloid Leukemia
  • CPI-613 + High Dose Cytarabine and Mitoxantrone
  • +3 more
  • Scottsdale, Arizona
  • +59 more
Jul 26, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • 6,8-bis(benzylthio)octanoic acid
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 26, 2018

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Winston-Salem (6,8-Bis(benzylthio)octanoic Acid, Docetaxel,

Withdrawn
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • 6,8-Bis(benzylthio)octanoic Acid
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 30, 2018

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Recurrent Small Cell Lung Cancer Trial in Winston-Salem (6,8-bis(benzylthio)octanoic acid)

Completed
  • Recurrent Small Cell Lung Cancer
  • 6,8-bis(benzylthio)octanoic acid
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Advanced Hematologic Malignancies Trial in Winston-Salem (CPI-613)

Completed
  • Advanced Hematologic Malignancies
  • CPI-613
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 29, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +6 more
  • CPI-613
  • +4 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

Untreated Adult Acute Myeloid Leukemia Trial in Winston-Salem (6,8-Bis(benzylthio)octanoic Acid, Cytarabine, Daunorubicin

Withdrawn
  • Untreated Adult Acute Myeloid Leukemia
  • 6,8-Bis(benzylthio)octanoic Acid
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023

Arthritis, Gouty Trial in Shanghai (SSGJ-613, Placebo)

Not yet recruiting
  • Arthritis, Gouty
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Jul 20, 2023

Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

Not yet recruiting
  • Mycosis Fungoides
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2023

Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

Active, not recruiting
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Salzburg, Austria
  • +39 more
Jan 18, 2023